Since altered promoter methylation has been associated with aberrantly transcriptional expression of the corresponding gene [26], we evaluated CD44 gene expression and found that the non-treated PCa cases with higher CD44 methylation levels displayed lower CD44 gene expression than the treated cases. This evidence concerns the gene CD44 and posterior cortical atrophy.